Hye-Kyung Kim
Director/Board Member bij ENZYCHEM LIFESCIENCES CORPORATION
Vermogen: 89 251 $ op 31-03-2024
Profiel
Hye-Kyung Kim is currently the Chief Executive Officer at Bridget Lifesciences Corp., Vice Chairman at ENZYCHEM LIFESCIENCES Corp., and Vice Chairman at Konex Association.
She completed her undergraduate degree at Ewha Womans University and her graduate degree at Korea National Open University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-04-2024 | 63 810 ( 0.08% ) | 89 251 $ | 31-03-2024 |
Actieve functies van Hye-Kyung Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Director/Board Member | 01-07-2012 |
Bridget Lifesciences Corp.
 Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Chief Executive Officer | 01-01-2003 |
| Konex Association | Director/Board Member | 01-01-2014 |
Opleiding van Hye-Kyung Kim
| Ewha Womans University | Undergraduate Degree |
| Korea National Open University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Finance |
| Konex Association |
